Cargando…
Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis
Metastasis, the chief cause of cancer-related deaths, is associated with epithelial-mesenchymal transition (EMT). In the tumor microenvironment, EMT can be triggered by chemokine/G-protein-coupled receptor (GPCR) signaling, which is closely associated with tumor progression. However, the functional...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578795/ https://www.ncbi.nlm.nih.gov/pubmed/36268282 http://dx.doi.org/10.1155/2022/2208176 |
_version_ | 1784812037335941120 |
---|---|
author | Tian, Xutengyue Wang, Jiayi Jiang, Lanxin Jiang, Yuchen Xu, Juan Feng, Xiaodong |
author_facet | Tian, Xutengyue Wang, Jiayi Jiang, Lanxin Jiang, Yuchen Xu, Juan Feng, Xiaodong |
author_sort | Tian, Xutengyue |
collection | PubMed |
description | Metastasis, the chief cause of cancer-related deaths, is associated with epithelial-mesenchymal transition (EMT). In the tumor microenvironment, EMT can be triggered by chemokine/G-protein-coupled receptor (GPCR) signaling, which is closely associated with tumor progression. However, the functional links between chemokine/GPCR signaling-mediated EMT and metastasis remain unclear. Herein, we summarized the mechanisms of chemokine/GPCR signaling-mediated EMT with an insight into facilitating metastasis and clarified the role of chemokine in the local invasion, intravasation, circulation, extravasation, and colonization, respectively. Moreover, several potential pathways that might contribute to EMT based on the latest studies on GPCR signaling were proposed, including signaling mediated by G protein, β-arrestin, intracellular, dimerization activation, and transactivation. However, there is still limited evidence to support the EMT programme functional contribution to metastasis, which keeps a key question still open whether we should target EMT programme of cancer cells. Answers to that question might help develop an anticancer strategy or guide new directions for anticancer metastasis therapy. |
format | Online Article Text |
id | pubmed-9578795 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-95787952022-10-19 Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis Tian, Xutengyue Wang, Jiayi Jiang, Lanxin Jiang, Yuchen Xu, Juan Feng, Xiaodong J Oncol Review Article Metastasis, the chief cause of cancer-related deaths, is associated with epithelial-mesenchymal transition (EMT). In the tumor microenvironment, EMT can be triggered by chemokine/G-protein-coupled receptor (GPCR) signaling, which is closely associated with tumor progression. However, the functional links between chemokine/GPCR signaling-mediated EMT and metastasis remain unclear. Herein, we summarized the mechanisms of chemokine/GPCR signaling-mediated EMT with an insight into facilitating metastasis and clarified the role of chemokine in the local invasion, intravasation, circulation, extravasation, and colonization, respectively. Moreover, several potential pathways that might contribute to EMT based on the latest studies on GPCR signaling were proposed, including signaling mediated by G protein, β-arrestin, intracellular, dimerization activation, and transactivation. However, there is still limited evidence to support the EMT programme functional contribution to metastasis, which keeps a key question still open whether we should target EMT programme of cancer cells. Answers to that question might help develop an anticancer strategy or guide new directions for anticancer metastasis therapy. Hindawi 2022-10-11 /pmc/articles/PMC9578795/ /pubmed/36268282 http://dx.doi.org/10.1155/2022/2208176 Text en Copyright © 2022 Xutengyue Tian et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Tian, Xutengyue Wang, Jiayi Jiang, Lanxin Jiang, Yuchen Xu, Juan Feng, Xiaodong Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis |
title | Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis |
title_full | Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis |
title_fullStr | Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis |
title_full_unstemmed | Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis |
title_short | Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis |
title_sort | chemokine/gpcr signaling-mediated emt in cancer metastasis |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578795/ https://www.ncbi.nlm.nih.gov/pubmed/36268282 http://dx.doi.org/10.1155/2022/2208176 |
work_keys_str_mv | AT tianxutengyue chemokinegpcrsignalingmediatedemtincancermetastasis AT wangjiayi chemokinegpcrsignalingmediatedemtincancermetastasis AT jianglanxin chemokinegpcrsignalingmediatedemtincancermetastasis AT jiangyuchen chemokinegpcrsignalingmediatedemtincancermetastasis AT xujuan chemokinegpcrsignalingmediatedemtincancermetastasis AT fengxiaodong chemokinegpcrsignalingmediatedemtincancermetastasis |